1 of 26

Experience the Future of Longevity

A Private Briefing �with Peter H. Diamandis, MD, Yianni Psaltis, PhD and Jackie Miller

2 of 26

100X over the decade ahead

“We will experience as much change in the next decade (2025 – 2035), as humanity had during the past century (1925 – 2025).”

— Ray Kurzweil

(2025 – 2035)

3 of 26

DRIVER: Exponential Growth in Compute

Moore’s Law (2x / 2 yrs)

10X/Yr

3

4 of 26

Extended Healthspan &

Longevity Escape Velocity

(2025 – 2035)

“By the early 2030’s, we will hit longevity escape velocity.”

— Ray Kurzweil

5 of 26

$101 Million Purse + $10M Bonus
Reverse age-related degradation by 20 years (goal):

Muscle
Immune
Cognition

Single treatment (1-year Tx)
7-year timeframe
Funding: Hevolution Fndtn (KSA)
> 730 Teams registered

$101M HEALTHSPAN

5

6 of 26

Future Of Surgery/Gallbladder Removal

JULY 2025: John Hopkins team built a fully autonomous surgical robot (No human control) – 100% accuracy, but currently slower than humans.

JAN 2026: Elon on Moonshots Podcast. Optimus is the future of Surgery.

6

https://www.cnet.com/news/elon-musk-unveils-tesla-bot-a-humanoid-robot-utilizing-vehicle-ai/

Elon Musk unveils Tesla Bot, a humanoid robot that uses vehicle AI

"It's intended to be friendly," the carmaker's CEO joked.

Tesla CEO Elon Musk on Thursday unveiled a humanoid robot called the Tesla Bot that runs on the same AI used by Tesla's fleet of autonomous vehicles. A functioning version of the robot didn't make an appearance during Musk's reveal, though a slightly bizarre dance by a performer dressed like a Tesla Bot did.

The unexpected reveal came at the end of Tesla's AI Day presentation, with Musk providing few details about the slightly creepy, Slenderman-like robot beyond a few PowerPoint slides. The 5-foot-8-inch robot is expected to weigh in at 125 pounds and be built from "lightweight materials," he said.

Its head will be kitted out with the autopilot cameras used by Tesla's vehicles to sense the environment and will contain a screen to display information. Internally, it will be operating via Tesla's Full Self-Driving computer.

"It's intended to be friendly," Musk joked, "and navigate through a world built for humans."

The robot's appearance came after a 90-minute presentation detailing some of the artificial intelligence upgrades driving Tesla's electric vehicles, including the Dojo supercomputer, which helps train cars to navigate city streets without human assistance. "It makes sense to put that onto humanoid form," Musk said.

Three slides detailed the robot's proposed specifications, and Musk made sure he pointed out that you could both outrun the Tesla Bot and "overpower" it. He has, in the past, railed against the use of robots as weapons and warned of the risks AI might pose -- once calling it the "biggest risk we face as a civilization." I guess if they're your incredibly slow, easy-to-overpower robots, the dangers are reduced.

"We should be worried about AI," Musk reiterated during a question and answer session after the presentation. "What we're trying to do here at Tesla is make useful AI that people love and is ... unequivocally good."

One particular slide said the Tesla Bot would eliminate "dangerous, repetitive, boring tasks," and Musk provided an example, suggesting the robot could be told to "go to the store and get ... the following groceries." Not that such a task is particularly dangerous, but you might find it repetitive and boring.

Musk, prone to making bold statements about the future, riffed a little on how he envisions Tesla Bot changing the future of work, too. "This, I think, will be quite profound," he said. "Essentially, in the future, physical work will be a choice. If you want to do it, you can, but you won't need to do it."

It's hard to say how far off such a future might be, but there's a huge gap between showing off a few PowerPoint slides and delivering an actual, working humanoid robot. It's probably going to be a long while before you get your bread and milk via the Tesla Bot, but, Musk said, a prototype will likely be ready next year.

7 of 26

VITARI: $100 Genome Sequencing Device

Generates 3 TB of data during 36-hour sample processing runs.

Combines factory-level scale with compact design.

7

8 of 26

FDA Greenlights Partial Epigenetics Trials In Humans (David Sinclair’s Life Biosciences)

Life Biosciences received FDA clearance for ER-100, marking the first human trial of cellular reprogramming technology targeting optic neuropathies (Glaucoma and NAION).

The breakthrough uses partial cellular reprogramming with three Yamanaka Factors (OSK). Clinical trial begins March 2026.

Trial represents a paradigm shift toward treating epigenetic drivers of aging rather than downstream symptoms.

8

9 of 26

Eliminating All Disease By 2035

9

10 of 26

Doubling of Human Lifespan in 5-10 Yrs

10

11 of 26

An “Age-Reversal Pill”

David Sinclair, PhD

11

12 of 26

7 Of The Top 10 Causes Of Death In America Are Preventable

Fountain Life focuses on FINDING, PREVENTING and ELIMINATING conditions that shorten life or sap quality and vitality.

12

13 of 26

Fountain Life’s First 5,000 Members

14.4%

of seemingly healthy members have an actionable, life-threatening finding.

3.4%

of members, we detect cancer.

2.1%

of members, we detect an aneurysm.

13

14 of 26

Abundance Longevity Trip

“Your Personal Blue Zone”

October 7–11, 2026

San Francisco, California

15 of 26

The Abundance Longevity Trip

30+ Top Speakers
Breakthrough Science
Advanced Diagnostics
Key Therapeutics

October 7–11, 2026 | San Francisco, CA

15

16 of 26

Longevity Topics

Longevity & Biotech 101
Sleep, Diet, & Exercise
Reproductive & Women’s Health
Peptides
Oral Health / Dentistry
Neurodegenerative Disease
Muscle Function & Exercise

Advanced Diagnostics & Imaging
Aesthetic Medicine: Skin & Hair
Cryogenics & Cryonics
Epigenetic Reprogramming
Hearing Loss Rejuvenation
Genomic Screening

16

17 of 26

Abundance Longevity Faculty

Alexander Grinberg, MD

Leading Peptide Expert

Mark Woodward, PhD

Founder & CEO, WakeBio

Kian Sadeghi

Founder & CEO, �Nucleus Genomics

Sophie Bai

Founder & CEO,

B.A.I. Biosciences

Dawn Mussallem, DO

CMO, Fountain Life

Emily Stein

Founder & CEO, �Gaia Health

Joe Betts-LaCroix

CEO, Retro Biosciences

Karan Singhal

Health AI, Open AI

…and many more!

17

18 of 26

Plus!

20+ Additional Faculty

Access to my Personal Network of MDs and Investment Associates:

4 MDs (in-room, supporting your needs)
Biotech Sector Experts

18

19 of 26

High-Level Trip Schedule

Day 0

Arrivals, Introductions, Longevity Experiences

Day 1

Foundations, Longevity Olympics Opening Ceremony

Day 2

The Future of Longevity @ The Buck Institute

Day 3

AI-Powered Discovery & Frontier Innovation

Day 4

Breakthroughs in Human Potential & Longevity Olympics Closing Ceremony

Day 5

Reflections, Closing Conversations & Departure

Arrival

Departure

19

20 of 26

Longevity Experiences

Therapeutics

Diagnostics

Fitness & Wellness

20

21 of 26

Fountain Life Longevity Lounge

Recovery: IVs, sauna, cold plunge, red light therapy
Diagnostics: precision scanning, disease screening, biomarker testing
Fitness: wearables, devices, training
Sleep: wearables, trackers and coaching
Diet & Nutrition: trackers, supplements and products
Beauty: supplements and products for skin, hair, and teeth
Mental Health: meditation and mindset

21

22 of 26

Longevity Olympics

Fitness, biometrics, and nutrition challenges
Tracked by wearable devices
Daily trivia with Peter
Developing habits and routines from Peter’s Longevity Guidebook

22

23 of 26

Members Join for 3 Reasons

Investment Opportunities

Optimize �Health Solutions

Expand Knowledge

Every Member is interviewed in advance to understand your primary objectives (for our team to support).

23

24 of 26

What Attendees Say…

“I run a multi-billion dollar biotech investment portfolio… the Longevity Trip gives me access to the cutting edge in science.”�– Daniel Krizek, Portfolio Manager, Citadel (Surveyor)

“Every year, I fly from India for a week to participate. I can’t think of a more compelling use of my time.”�– Mukesh Bansal, Founder, Curefit

"This event has profoundly changed my mindset as a physician. My previous understanding of lifespan has been completely shattered.” �– Dr. Ellen Liu, MD, PHD, MBA

24

25 of 26

Investment to Attend

Individual Attendee	Two Attendees �* Sharing a Room
$80,000	$75,000 Per Person
Includes: Luxury five-star accommodations Private executive transportation Premium diagnostics and therapeutics Tailored wellness treatments and fitness regimens Gourmet nutrient-optimized cuisine & beverages included

25

26 of 26

Next Steps

Interested in joining us?

Learn more about the Trip here.

A360.com/Longevity

26